Celecoxib

Celecoxib is a COX-2 selective inhibitor — a subclass of NSAIDs designed to preferentially block the cyclooxygenase-2 (COX-2) enzyme while largely sparing COX-1 ^[1][2].

The rationale behind COX-2 selectivity is that COX-2 is the primary enzyme induced at sites of inflammation, where it drives the production of prostaglandins responsible for pain, swelling, and fever. COX-1, by contrast, is constitutively expressed in the stomach, kidneys, and platelets, producing prostaglandins that protect the gastric mucosa, regulate kidney blood flow, and support platelet aggregation ^[2].

By selectively inhibiting COX-2 while leaving COX-1 relatively intact, celecoxib aims to provide anti-inflammatory and analgesic effects without the GI mucosal damage caused by traditional NSAIDs ^[1]. Clinical trials have confirmed that celecoxib causes significantly fewer endoscopic ulcers — the CLASS and SUCCESS studies showed approximately 50-70% fewer GI ulcers compared to traditional NSAIDs like ibuprofen and diclofenac ^[3].

However, the COX-2 selectivity also means celecoxib does not inhibit platelet aggregation, since platelet COX-1 is spared ^[2]. This was initially a concern regarding cardiovascular safety, as the related drug rofecoxib (Vioxx) was withdrawn in 2004 due to increased heart attack risk. The large PRECISION trial (2016) subsequently showed that celecoxib at moderate doses (200 mg/day) was non-inferior to ibuprofen and naproxen for cardiovascular safety ^[4].

When starting celecoxib for arthritis, most patients notice meaningful pain improvement within 1-3 days, with the full anti-inflammatory effect developing over 1-2 weeks of regular use ^[1].

The main advantage you may notice compared to traditional NSAIDs is fewer stomach problems. Studies show significantly fewer ulcers, less heartburn, and fewer GI complaints with celecoxib compared to ibuprofen or naproxen ^[3].

Celecoxib does not provide antiplatelet protection — if you need cardiovascular protection, you will still need low-dose aspirin separately. Unlike traditional NSAIDs, celecoxib does not interfere with aspirin's antiplatelet effect ^[2].

Common early side effects include mild headache, diarrhea, and upper respiratory symptoms. These are generally mild and often resolve with continued use ^[1]. Report any signs of fluid retention (swelling, weight gain) or cardiovascular symptoms (chest pain, shortness of breath) to your doctor.

Food: Celecoxib can be taken with or without food ^[1]. A high-fat meal increases absorption by 10-20% and delays peak levels by 1-2 hours. For patients with GI sensitivity, taking with food is reasonable, though the GI-sparing advantage of COX-2 selectivity means food is less important for GI protection than with traditional NSAIDs.

Capsule Administration: For patients who cannot swallow capsules, the contents can be sprinkled on applesauce and consumed immediately ^[1]. The entire capsule contents should be sprinkled on a level teaspoon of cool or room-temperature applesauce.

Alcohol: As with all NSAIDs, alcohol increases GI bleeding risk. Though celecoxib has a better GI safety profile, combining it with alcohol is still not recommended, especially for chronic use ^[1].

Sulfa Allergy: Celecoxib contains a sulfonamide moiety. Although true cross-reactivity with sulfonamide antibiotics is extremely rare and likely overstated, caution is traditionally advised in patients with documented sulfa allergy ^[5].

Osteoarthritis: 200 mg once daily or 100 mg twice daily ^[1].

Rheumatoid Arthritis: 100-200 mg twice daily ^[1].

Ankylosing Spondylitis: 200 mg once daily or 100 mg twice daily; may increase to 400 mg/day if inadequate response after 6 weeks ^[1].

Acute Pain / Dysmenorrhea: 400 mg initially, then 200 mg on the first day if needed; then 200 mg twice daily as needed ^[1].

Juvenile Rheumatoid Arthritis (2+ years): - 10-25 kg: 50 mg twice daily - >25 kg: 100 mg twice daily ^[1]

CYP2C9 Poor Metabolizers: Start at half the lowest recommended dose (e.g., 50 mg daily for OA) ^[1].

Hepatic Impairment: Reduce dose by 50% in moderate hepatic impairment (Child-Pugh B). Avoid in severe impairment ^[1].

Key Principle: Use the lowest effective dose for the shortest duration. Doses above 200 mg BID have not been studied in long-term clinical trials.

Generic celecoxib became available in 2014 when the Celebrex patent expired, significantly reducing costs. A 30-day supply of generic celecoxib 200 mg costs approximately $15-30, compared to $250+ for brand-name Celebrex ^[6].

Cost-saving strategies: - Generic substitution: Generic celecoxib is FDA "AB" rated as therapeutically equivalent to Celebrex and is now the standard dispensed formulation - Once-daily dosing for OA: 200 mg once daily is as effective as 100 mg BID for osteoarthritis and simplifies dosing - GoodRx coupons: Can reduce costs to $10-20 for a 30-day supply - Compare with OTC NSAIDs + PPI: For patients without high GI risk, generic naproxen or ibuprofen combined with generic omeprazole may be even cheaper while providing similar GI protection - Insurance formulary: Celecoxib generic is now on most insurance formularies at preferred tier pricing - Patient assistance programs: Pfizer's patient assistance may still cover Celebrex for uninsured patients

Pregnancy (Category C before 30 weeks; D at 30+ weeks): Like all NSAIDs, celecoxib is contraindicated starting at approximately 20 weeks gestation due to risks of oligohydramnios and fetal renal dysfunction ^[1][7]. It is absolutely contraindicated after 30 weeks due to premature ductus arteriosus closure. Animal studies showed increased incidence of skeletal malformations at doses 6x the human dose. Use before 20 weeks only if clearly needed.

Breastfeeding: Celecoxib is excreted in breast milk in low concentrations. Limited data suggest infant exposure is very low ^[8]. However, ibuprofen remains the preferred NSAID during breastfeeding due to more extensive safety data. If celecoxib is used during breastfeeding, monitor the infant for GI effects.

Fertility: Like other NSAIDs, celecoxib may delay or prevent ovulation. This effect is reversible upon discontinuation ^[1].

Generic celecoxib became available in May 2014 following expiration of Pfizer's patent on Celebrex. Multiple manufacturers now produce generic celecoxib capsules (50 mg, 100 mg, 200 mg, 400 mg), all FDA "AB" rated as therapeutically equivalent to Celebrex.

The price dropped dramatically with generic entry — from $250-300/month for Celebrex to $15-30/month for generic. Today, generic celecoxib accounts for the vast majority of prescriptions filled.

Brand-name Celebrex is still technically available but is rarely stocked at pharmacies and offers no clinical advantage over the generic.